The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebul
![Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.00011-18/asset/1c3c0b88-5f94-4150-aaff-531f6da0c2b7/assets/graphic/zac0061872290001.jpeg)
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy
![PDF) IN VITRO ASSESSMENT OF AEROSOLIZED AMIKACIN LUNG DOSE DELIVERED BY NKTR-061 PDDS CLINICAL DURING ON-VENTILATOR AND OFF-VENTILATOR USE PDF) IN VITRO ASSESSMENT OF AEROSOLIZED AMIKACIN LUNG DOSE DELIVERED BY NKTR-061 PDDS CLINICAL DURING ON-VENTILATOR AND OFF-VENTILATOR USE](https://www.researchgate.net/profile/Nani-Kadrichu/publication/278297310/figure/tbl1/AS:614002572947463@1523401029825/n-vitro-study-parameters-on-vent-and-handheld-configurations_Q320.jpg)
PDF) IN VITRO ASSESSMENT OF AEROSOLIZED AMIKACIN LUNG DOSE DELIVERED BY NKTR-061 PDDS CLINICAL DURING ON-VENTILATOR AND OFF-VENTILATOR USE
![Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease | European Journal of Drug Metabolism and Pharmacokinetics Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease | European Journal of Drug Metabolism and Pharmacokinetics](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs13318-020-00669-7/MediaObjects/13318_2020_669_Fig2_HTML.png)
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease | European Journal of Drug Metabolism and Pharmacokinetics
This handout provides distribution information for ARIKAYCE® (amikacin liposome inhalation suspension).
![Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia – topic of research paper in Medical engineering. Download scholarly article PDF and read for Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia – topic of research paper in Medical engineering. Download scholarly article PDF and read for](https://cyberleninka.org/viewer_images/154625/f/1.png)
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia – topic of research paper in Medical engineering. Download scholarly article PDF and read for
![Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-86342-8/MediaObjects/41598_2021_86342_Fig2_HTML.png)
Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports
![Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1569199319308331-gr1.jpg)
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect
![Mean cumulative systemic absorption of amikacin as a function of time.... | Download Scientific Diagram Mean cumulative systemic absorption of amikacin as a function of time.... | Download Scientific Diagram](https://www.researchgate.net/profile/Stephan-Ehrmann/publication/5800487/figure/fig4/AS:277672988037128@1443213807809/Mean-cumulative-systemic-absorption-of-amikacin-as-a-function-of-time-Absorption-is_Q320.jpg)